JOURNAL OF BUON, vol.24, no.4, pp.1719-1726, 2019 (SCI-Expanded)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded (SCI-EXPANDED), Scopus
tyrosine kinase inhibitors, drug-drug interactions, antibiotics, proton pump inhibitors, cancer, CANCER-PATIENTS, P-GP, ABSORPTION, PHARMACOKINETICS, KETOCONAZOLE, PREVALENCE, MEDICATION, METABOLISM, PAZOPANIB, AGENTS
Gazi University Affiliated:
Purpose: Tyrosine kinase inhibitors (TKIs) are frequently used drugs in oncology practice. Although oral administration is an advantage, long-term use increases potential drug-drug interaction risk. The purpose of this study was to assess the prevalence of potential TKI-drug interaction (PTDI) in patients who used TKIs and increase awareness of this subject.